{
    "organizations": [],
    "uuid": "0581849c36e446c6d9e9970b8c12eb9dc55c0b4d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-targovax-early-signal-of-efficacy/brief-targovax-early-signal-of-efficacy-in-oncos-102-trial-in-mesothelioma-idUSASO00043R",
    "ord_in_thread": 0,
    "title": "BRIEF-Targovax: Early Signal Of Efficacy In ONCOS-102 Trial In Mesothelioma",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 2 (Reuters) - Targovax ASA:\n* REG-TARGOVAX ANNOUNCES EARLY SIGNAL OF EFFICACY IN ONCOS-102 TRIAL IN MESOTHELIOMA\n* SAYS ENCOURAGING RESULTS FROM ITS PHASE I/II TRIAL OF ONCOS-102 IN MESOTHELIOMA Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-05-02T13:08:00.000+03:00",
    "crawled": "2018-05-03T12:28:15.011+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "targovax",
        "asa",
        "announces",
        "early",
        "signal",
        "efficacy",
        "trial",
        "mesothelioma",
        "say",
        "encouraging",
        "result",
        "phase",
        "trial",
        "mesothelioma",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}